Plasma free fatty acid (FFA) concentrations are increased in states of insulin resistance and impair endothelial function. Because the underlying mechanisms are largely unknown, we examined selected, purified FFAs' (100-300 µmol/l, 24-48 h) action on apoptosis, cell cycle distribution, and associated gene/protein expression in human umbilical vein endothelial cells (HUVECs). Stearic acid, but not oleic acid, time and concentration dependently increased endothelial apoptosis by fivefold (n=6, P<0.01), whereas polyunsaturated FFAs (PUFAs; linoleic, γ-linolenic, and arachidonic acid) exerted proapoptotic activity only at 300 µmol/l (P<0.05). Proapoptotic FFA action increased with FFAs' number of double bonds and with protein expression of the apoptosis promotor bak. The G 0 /G 1 cell cycle arrest (n=6, P<0.05) induced by stearic acid (+14%) and PUFAs (+30%) is reflected by up-regulation of p21 . In addition, all FFAs concentration dependently reduced (P<0.05) gene/protein expression of clusterin (-54%), NF-κB's inhibitor, IκBα (-50%), endothelin-1 (-44%), and endothelial NO synthase (-44%). Plasma samples obtained from individuals with elevated plasma FFAs (372±22 µmol/l) increased endothelial apoptosis by 4.2-fold (P<0.001, n=10) compared with intraindividually matched low plasma FFA (56±21 µmol/l) conditions, underlining the results obtained by defined FFA stimulation. In conclusion, FFA structure differently affects endothelial cell proliferation and apoptosis, both representing key factors in the development of micro-and macrovascular dysfunction.
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Key words: endothelial dysfunction • vascular complications • diabetes lasma concentrations of free fatty acids (FFAs) are increased in states relating to the metabolic syndrome, including hypertension (1), obesity (2) , and diabetes (3) . FFAs have been shown to impair skeletal muscle insulin sensitivity (4-9) and endothelium-dependent vasodilation (8, 10) . Damage of vascular cells by proatherosclerotic risk factors (e.g., hyperglycemia, oxidized proteins/lipids, and inflammatory cytokines) leads to endothelial dysfunction preceding manifest vascular complications (11, 12) .
P
In humans, FFA-mediated endothelial dysfunction could relate to reduced availability of Larginine or NO (13) and to oxidative stress (14) . In vitro, selected FFAs have been shown to modulate endothelial expression and secretion of adhesion molecules (15) and coagulation (16) , vasoactive (17) , and inflammatory factors (18) . Limited knowledge, however, exists on the potential of FFAs to directly affect endothelial apoptosis (19, 20) , a key element of endothelial dysfunction as well as of overt micro-and macrovascular disease, including diabetic retinopathy and atherosclerosis (12, 21, 22) . The mechanistic basis of these phenomena is largely unknown. Answering this question could be very important because endothelial cells undergoing apoptosis seem to impair the integrity of the endothelial monolayer and its barrier function, to trigger atherosclerotic plaque erosion and plaque rupture, and to favor coronary thrombosis by their proadhesive and procoagulatory activity (11, 12, 22) .
Note that the cell's apoptotic death results from the loss of intra-and extracellular survival signals and/or from the increase of death signals. These include the red/ox sensitive transcription factor NF-κB (23); pro-(e.g., bak; 24) and antiapoptotic (e.g., bcl-2; 25) members of the bcl-2 family; the multifunctional, chaperone-like molecule clusterin (apolipoprotein J; 26); and regulators of vascular tone such as the vasoconstrictor endothelin-1 (ET-1; 27) and endothelial NO synthase (eNOS; 28), the latter catalyzing the release of the vasodilator NO from L-arginine. In addition, cell cycle regulatory molecules such as cyclins and inhibitors of cyclin-dependent kinases such as p21 WAF-1/Cip1 are involved in apoptosis and cell cycle progression (29, 30) .
This study was therefore designed to characterize in detail the molecular background of a potentially detrimental action of increased selected and human total plasma FFA concentrations on a) apoptosis, b) cell cycle progression, and c) associated gene/protein expression in human umbilical vein endothelial cells (HUVECs).
MATERIALS AND METHODS

Reagents
M199, fetal bovine serum, Triton X-100, Nonidet P-40, Na 3 VO 4 , β-glycerophosphate, PMSF, aprotinine, leupeptine, collagenase, stearic acid, oleic acid, linoleic acid and linoleic acidalbumin (=albumin-conjugated linoleic acid), γ-linolenic acid, arachidonic acid, and propidium iodide were purchased from Sigma (St. Louis, MO). Phosphate-buffered saline (PBS), Lglutamine, and antibiotics were from Hyclone (Logan, UT). EDTA, NaCl, NaN 3 , MgCl 2 , NaOH, NaHCO 3 , Tris, HEPES, ethanol, and formaldehyde were from Merck (Darmstadt, Germany).
32 P]γATP, Megaprime DNA labeling system, and horse radish peroxidase (HRP)-labeled sheep anti-mouse Ig were from Amersham Pharmacia (Buckinghamshire, UK). DNase I and RNase A were purchased from Boehringer (Mannheim, Germany). RNAzol was from Cinna Biotecx (Houston, TX), and the TdT-FragEL kit was from Oncogene (Boston, MA). Agarose, SDS, and Tween-20 were from Bio-Rad (Hercules, CA), and Super Signal Substrate was from Pierce (Rockford, IL). The p53 antibody was from Santa Cruz Biotechnology (Santa Cruz, CA). Antibodies against IκBα, Phospho-IκBα, p21
WAF-1/Cip1 , cyclin D3, and eNOS were from Transduction Laboratories (Lexington, KY), those against bcl-2 and bak were from Calbiochem (Cambridge, MA), and that against clusterin was from Alexis (Switzerland). The Escherichia coli clone HHCD19, containing clusterin as an insert, was from the ATCC (Rockville, MD), the pre-proendothelin-1 cDNA probe was a kind gift of Linette
Preparation of plasma samples containing high FFA concentrations
Fluor-EDTA blood samples were drawn from four healthy volunteers before (pre-intralipid) and after (post-intralipid) an infusion of 500 ml of an oil-in-water emulsion (intralipid 20%; 35). Blood was immediately centrifuged, and plasma was stored at -80°C until further analysis. Intralipid infusion did not affect serum cholesterol (140±71 mg/dl vs. 147±60 mg/dl) but increased serum triglycerides from 90 ± 29 mg/dl to 206 ± 59 mg/dl and plasma FFAs from 518 ± 259 µmol/l to 2432 ± 1645 µmol/l. Pre-and post-intralipid plasma samples were digested with lipoprotein lipase (30 U/ml, 3 h at 37°C) to eliminate triglycerides, thereby further increasing FFA concentrations to 1107 ± 422 µmol/l (pre-intralipid) and 7106 ± 1753 µmol/l (postintralipid).
To test the effects of endogenously synthesized FFAs, another volunteer received i.v. heparin (0.1 IU/kg/min) to stimulate endogenous triglyceride breakdown. In this subject, heparin infusion slightly reduced serum cholesterol from 324 mg/dl to 313 mg/dl and triglycerides from 2742 mg/dl to 2430 mg/dl, but it increased plasma FFAs from 430 µmol/l to 3867 µmol/l. Plasma FFA concentrations were assayed with a microfluorometric method (Wako Chemical, Richmond, VA) as described previously (35) . The clinical study protocol was approved by the local ethics board and informed consent was obtained from all participants after the nature and potential consequences of the protocol had been explained to them.
Incubation of HUVECs with selected FFAs
HUVECs were exposed either to FFAs (100-300 µmol/l; stearic acid, C18:0, oleic acid, C18:1ω9, linoleic acid, C18:2ω6, γ-linolenic acid, C18:3ω6, arachidonic acid, C20:4ω6) or to the respective ethanol (used as a solvent) concentration (1-3 ppm, control) in M199 supplemented with 20% delipidated fetal bovine serum (final concentration of albumin, 0.4%) and antibiotics. Experimental and intra-individual control cultures were tested for apoptosis, cell cycle distribution, and associated gene/protein expression after 24 and/or 48 h.
Incubation of HUVECs with human plasma FFA samples
HUVECs were incubated with pre-and post-intralipid plasma and diluted in full growth medium (final concentration of albumin, 0.8%) to final FFA concentrations of 59±23 µmol/l and 369±24 µmol/l, respectively, or with pre-and postheparin plasma, diluted in full growth medium to final FFA concentrations of 43 µmol/l and 387 µmol/l, respectively. After 24 or 48 h, apoptosis was determined as described below.
[ 3 H]Thymidine apoptosis assay
HUVECs were grown to confluence in the presence of [ 3 H]thymidine (1µCi/ml), trypsinized, and seeded into 24-well culture plates (60,000 cells per well). After adherence (4 h) and exposure (24-48 h) to FFAs vs. ethanol or to proband plasma high in FFAs vs. the respective intra-individual control low in FFAs, cells were lysed (20 mmol/l Tris.Cl, pH 7.5, 0.4% Triton X-100; 10 min on ice), and fragmented (apoptotic) DNA was separated by centrifugation (31) (32) (33) (34) . Radioactivity of fragmented vs. total DNA (digested with 180µg/ml DNase I) was quantitated in triplicates using a 1900 TR Liquid Scintillation Analyser (Canberra Packard Meriden, CT). Results are expressed as fragmented DNA as percentage of total DNA. In time lapse studies, apoptosis is given in relation to control cultures, treated with the respective ethanol concentration (set to 100%).
In situ apoptosis staining
After exposure (48 h) of endothelial cells to FFAs or ethanol control, apoptosis was determined using the TdT-FragEL kit according to the manufacturer's instructions (31, 34) . In brief, after fixation (ice-cold methanol), permeabilization (Triton X-100 0.2% in PBS), and equilibration (TdT-equilibration buffer 1:5 in dH 2 O), apoptotic cells were labeled (1 h, 37°C, 95% relative humidity) with biotin-dNTP by use of TdT-enzyme (1:20 in TdT labeling reaction mix) and were subsequently conjugated with Streptavidin-HRP solution (1:50 in blocking buffer; 30 min, room temperature). Colorless diaminobenzidine was then converted by HRP into an insoluble brown color. Counterstaining with methyl green was used to quantitate viable (green) vs. apoptotic (brown) cells by counting at least 1000 nuclei in multiple fields in a blinded fashion under the microscope. Rates of apoptosis are given as percent of positively stained nuclei (brown) to total nuclei in relation to control cultures treated with ethanol (set to 100%).
Cell cycle analysis
Actively growing HUVECs were exposed (48 h) to 300 µmol/l of the different FFAs compared with control cultures treated with ethanol. Subsequently, cells were washed and scraped off the dishes in PBS. After centrifugation (200 g, 10min, 4°C), HUVECs were fixed (1h, -20°C) in ice cold ethanol (75%). Total DNA was stained after another washing step with propidium iodide (1µg/ml in PBS containing 50µg/ml RNase A). Cell cycle distribution was then determined by FACS (fluorescence activated cell sorting) analyses (36) using a FACS Calibur (Becton Dickinson, Heidelberg, Germany). Data are presented as percent of viable cells remaining in the respective cell cycle phase.
Western blot analyses
Western blot analyses was done as described previously (31, 33, 34) . In brief, endothelial cells exposed (24 h) to FFAs vs. ethanol control were rinsed with cold PBS, lysed in cold Weinberg buffer (50 mmol/l HEPES pH 7.0, 0.5% Nonidet P-40, 250 mmol/l NaCl, 5 mmol/l EDTA, 5 mmol/l NaF, 0.2 mmol/l Na 3 VO 4 , 50 mmol/l β-glycerophosphate, 1 mmol/l PMSF, 2 mmo/l benzamidine, 10 µg/ml aprotinine, 10 µg/ml leupeptine) and a freeze-thaw cycle. After removing cellular debris by centrifugation (15,000g, 10 min, 4°C), aliquots of the supernatant, containing 10 µg total protein, were subjected to SDS polyacrylamide gel electrophoresis and subsequently transferred onto nitrocellulose membranes (Schleicher & Schüll, Kassel, Germany). Blocking of unspecific binding sites with nonfat dry milk (5% in Tris-buffered saline containing 0.05% Tween-20) was followed by incubation with primary antibodies (IκBα and p53 1:1000; p21 WAF-1/Cip1 , cyclin D3, eNOS, and clusterin 1:500; Phospho-IκBα 1:250; bak 1:100; bcl-2 1:50), which were deteceted with HRP-conjugated anti-mouse IgG using Super Signal Substrate. Protein expression was calculated in relation to intra-individual control cultures, exposed to ethanol (set to 100%).
Northern blot analyses
Cellular RNA was extracted as previously described (31-33) from HUVECs exposed (24 h) to the different FFAs or ethanol (control). Total RNA (20µg per lane) was electrophoresed on 1% formaldehyde agarose gels, transferred (vacuum) onto Hybond N nylon membranes (Amersham International, Buckinghamshire, UK) and UV crosslinked at 254 nm (5 min). cDNA probes (clusterin, ppET-1) were labeled with [α-32 P]dCTP using the Megaprime DNA labeling system, whereas the 28S-rRNA oligonucleotide probe, used to correct for loading inequalities, was labeled with [ 32 P]γATP by the kinase reaction. Prehybridization, hybridization, and washing steps were carried out as described previously (31) (32) (33) . RNA expression was calculated in relation to intra-individual control cultures, exposed to ethanol (set to 100%).
Densitometry of autoradiographies
Western and Northern blots were exposed to Kodak XAR5-Omat films, and semiquantitative evaluation of visualized bands was carried out by densitometry (gel documentation system, MWG Biotech, Ebersberg, Germany) using Gene Profiler 3.56 for Windows (Scanlytics) over multiple exposures to verify that readings were in the linear range.
Statistics
Data are expressed as means ± SE. Statistical analysis was performed using paired samples t test (SPSS for Windows 7.5.1) with Bonferroni correction for multiple comparisons. If not stated otherwise, n = 6 cultures were used for apoptosis and cell cycle experiments and n = 5 cultures for Western and Northern blot analyses.
RESULTS
FFA-modulated apoptosis
Using [
3 H]thymidine apoptosis assays, stearic acid (C18:0; 24 h), a saturated fatty acid (SFA), concentration dependently increased (Fig. 1A) , whereas oleic acid (C18:1ω9), a monounsaturated fatty acid (MUFA), did not affect apoptosis in HUVECs (Fig. 1B) . The PUFAs, linoleic (C18:2ω6; Fig. 1C ), γ-linolenic (C18:3ω6; Fig. 1D ), and arachidonic acid (C20:4ω6; Fig. 1E ), induced endothelial apoptosis only at the highest concentration used (300 µmol/l). Extending HUVECs' exposure to the different FFAs (300 µmol/l) from 24 h (hatched/gray bars) to 48 h (black bars) further increased apoptosis, which was then also triggered by oleic acid (Fig. 1F) . The observed apoptotic activity increased (P<0.001) with the number of double bonds (24 h: r=0.75; 48 h: r=0.66).
Albumin-conjugated linoleic acid (C18:2ω6; 24 h, 300 µmol/l) increased apoptosis in HUVECs to 299% of control cells exposed to 150 µmol/l BSA (set to 100%). It thereby exhibited identical proapoptotic activity as free linoleic acid (290% of control; compare Fig. 1C and 1F) . BSA (150 µmol/l) per se (serving as control) did not affect apoptosis in HUVECs (data not shown).
Rates of apoptosis in HUVECs treated with γ-linolenic acid (C18:3ω6; 48 h, 300 µmol/l) were 457 ± 72% (P<0.01) compared with intra-individual vehicle-treated control cells (set to 100%) when determined by in situ staining and thus confirmed results obtained by [ 3 H]thymidine apoptosis assays (389±82% of control; compare Fig. 1F ).
High FFA plasma obtained from four volunteers after intralipid infusion (mean FFA concentration: 369±24 µmol/l) and from one volunteer after heparin infusion (FFA concentration: 387 µmol/l) induced a 1.9-fold (P<0.01) and 4.2-fold (P<0.001) increase of apoptosis in HUVECs after 24 h ( Fig. 2A ) and 48 h (Fig. 2B ) of exposure, respectively, when compared with cells treated with the intra-individual low FFA (56±21 µmol/l) control samples.
FFA-modulated cell cycle distribution
Stearic acid (C18:0; 300 µmol/l, 48 h) increased the number of HUVECs in G 0 /G 1 phase of the cell cycle and reduced that of S-phase cells without affecting the number of cells in G 2 /M phase (Fig. 3B ) compared with intra-individual ethanol-treated control cells (Fig. 3A) . Whereas oleic acid (C18:1ω9) only marginally diminished the number of S-phase cells (Fig. 3C) , PUFAs (C18:2ω6, C18:3ω6, C20:4ω6; 300 µmol/l) caused a marked G 0 /G 1 cell cycle arrest by concomitantly reducing numbers of cells in S and G 2 /M phase ( Fig. 3D-F) .
FFA-modulated gene/protein expression-apoptosis-related molecules
In HUVECs, protein expression of the apoptosis promotor, bak, was concentration dependently increased by stearic acid (C18:0; Fig. 4A ) but not by oleic acid (C18:1ω9). PUFAs (C18:2ω6, C18:3ω6, C20:4ω6), however, induced endothelial up-regulation of bak only at concentrations of 300 µmol/l (Fig. 4A) . The proapoptotic activity of both stearic acid (r=0.99, P<0.01) and unsaturated FFAs (r=0.96, P<0.05) tightly correlated with endothelial protein expression of bak, whereas all tested FFAs reduced protein expression of the apoptosis inhibitor bcl-2 (≈-23%) independent of their respective apoptotic activity (Fig. 4B ).
Both protein (Fig. 5) and mRNA (at 300 µmol/l: C18:0: -61±5%, P<0.001; C18:1ω9: -51±12%, P<0.01; C18:2ω6: -59±12%, P<0.001; C18:3ω6: -51±13%, P<0.05; C20:4ω6: -56±9%, P<0.01) expression of the multifunctional molecule clusterin were reduced in HUVECs exposed to FFAs.
All FFAs tested concentration dependently reduced protein expression of NF-κB's inhibitor, IκBα (at 300 µmol/l: C18:0, -52±11%, P<0.01; C18:1ω9, -53±13%, P<0.05; C18:2ω6, -57±5%, P<0.001; C18:3ω6, -43±10%, P<0.05; C20:4ω6, -53±13%, P<0.05; Fig. 6A ), being in line with a concentration-dependent increase of phospho-IκBα up to 203 ± 25% (P<0.05; data not shown within figure) observed upon exposure of HUVECs (n=3) to 300 µmol/l linoleic acid (C18:2ω6) compared with intra-individual ethanol-treated control cells, set to 100%.
In HUVECs, FFAs dose dependently reduced eNOS protein expression (at 300 µmol/l: C18:0, -41±12%, P<0.05; C18:1ω9, -38±9%, P<0.05; C18:2ω6, -48±7%, P<0.01; C18:3ω6, -51±7%, P<0.001; C20:4ω6, -44±8%, P<0.01; Fig. 6B ) and pre-proendothelin-1 (ppET-1) mRNA expression (at 300 µmol/l: C18:0, -49±5%, P<0.001; C18:1ω9, -37±9%, P<0.05; C18:2ω6, -47±12%, P<0.05; C18:3ω6, -37±9%, P<0.05; C20:4ω6, -41±11%, P<0.05; Fig. 6C ).
FFA-modulated protein expression-cell cycle-related molecules
Independent of the respective FFAs' capability to delay cell cycle progression, all FFAs tested reduced endothelial cyclin D3 protein expression by ≈36%, as depicted in Figure 7A .
Stearic acid (C18:0) and PUFAs (C18:2ω6, C18:3ω6, C20:4ω6), but not oleic acid (C18:1ω9), increased expression of the inhibitor of cyclin-dependent kinases p21
WAF-1/Cip1 (Fig. 7B ) showed close correlation (r=0.94, P<0.01) with the number of cells residing in the G 0 /G 1 phase of the cell cycle (Fig. 7B) .
FFAs, however, did not affect protein expression of p53 (at 300 µmol/l: C18:0, -8±15%; C18:1ω9, +7±8%; C18:2ω6, +9±6%; C18:3ω6, +4±7%; C20:4ω6, -5±8%).
DISCUSSION
This study demonstrates induction by selected purified fatty acids of apoptosis in human vascular endothelial cells. The parallel observation of plasma FFA concentrations elevated in humans in vivo by intralipid or heparin infusion (37) to also trigger endothelial apoptosis supports the contention of a detrimental potential for the endothelium by FFAs in vivo.
FFAs' proapoptotic action is concentration-dependent (up to 300 µmol/l) for stearic acid, whereas polyunsaturated FFAs induce endothelial apoptosis only at a concentration of 300 µmol/l and in dependence on the number of fatty acid double bonds. In that context, note that different roles of saturated and unsaturated fatty acids have previously been described as to apoptosis in insulin-secreting RIN 1046-38 cells (38) , in pancreatic islets (39) , and in HL 60 cells (40) .
The observed saturation-related proapoptotic activity of polyunsaturated FFAs in endothelial cells could reflect the oxidizability of FFAs' double bonds and relate to the associated rise in oxidative stress, known to trigger endothelial dysfunction (11) and cell death (23, 41) . FFAinduced production of mitochondrial reactive oxygen species (ROS) is linked to activation of protein kinase C (PKC) and of the redox sensitive transcription factor NF-κB (42), assumed to be involved in the regulation of apoptosis (43, 44) . Because all FFAs, although exhibiting different proapoptotic activities, reduced IκBα expression (indicative for NF-κB activation [44] ) to a similar extent, we rule out a regulatory role of NF-κB in FFA-mediated cell death in HUVECs in the present setting.
FFAs' proapototic activities did not correlate with expression of the antiapoptotic and antioxidant molecule bcl-2 (25, 45) but did with that of the apoptosis promotor bak, which triggers mitochondrial release of death-promoting factors such as cytochrome c into the cytosol (24) . This culminates in the activation of caspases that effectuate linoleic acid-mediated apoptosis in porcine pulmonary artery endothelial cells (20) . Because the ratio of pro-and antiapoptotic bcl-2 family members determines the cells' susceptibility to cell death (24), FFAs' proapoptotic action could depend on increased bak expression. Such correlations, however, need to be interpreted with caution because they do not prove a causal relationship.
Originally described to be a marker of apoptosis (46) , clusterin (apolipoprotein J), as suggested by recent evidence, represents a feature of surviving cells and exerts atheroprotective effects (47) . Such atheroprotectivity is attributed to clusterin's antioxidative (48) , antiadhesive (49), or antiapoptotic potential (47) . Because, in our experimental setting, expression of clusterin was reduced to a similar extent by all FFAs tested, clusterin is unlikely to play a regulatory role in FFAs' proapoptotic activity in HUVECs. Nevertheless, diminished intracellular levels of clusterin-as induced by FFAs-could result in increased endothelial cell activation (47) and/or decreased defense mechanisms (50) promoting endothelial dysfunction.
The same situation applies to the vasoregulatory factors eNOS and endothelin-1 (ET-1), described to produce (eNOS) or to act (ET-1) as endothelial apoptosis survival factors (27, 28) . Because the expression of both molecules was reduced by all FFAs tested in a concentrationdependent manner and to a similar extent, no major role can be assigned to any of these molecules in the regulation of FFA-induced endothelial apoptosis. In addition, the downregulation by FFAs of NF-κB's putative target gene ET-1-in the presence of activated NF-κB (as shown by reduction of NF-κB's inhibitor IκBα)-suggests a NF-κB-independent mechanism to account for reduced ET-1 expression (51, 52) in HUVECs.
FFA-induced cell cycle arrest apparently occurs independently of ET-1, eNOS, and cyclin D3 expression but is in line with up-regulation of the inhibitor of cyclin-dependent kinases p21 WAF-1/Cip1 (53, 54) . Accumulation of endothelial cells in G 0 /G 1 and their reduction in S and G 2 M cell cycle phases indicate that FFA-mediated growth arrest occurs via inhibition of the cells' transition from the G 0 /G 1 to the S phase of the cell cycle. These findings are in line with upregulation of the universal inhibitor of cyclin-dependent kinases, p21
WAF-1/Cip1 , representing a well-known effectuator of G 1 cell cycle arrest in endothelial cells (55) . FFA-triggered, p21 WAF-1/Cip1 -mediated growth arrest is independent of p53 up-regulation, which-in contrast to different experimental setups (56)-has already been described in endothelial cells (31, 34) .
Because FFAs' proapoptotic action parallels their respective antiproliferative activity (G 0 /G 1 cell cycle arrest), it seems possible that the latter represents a prerequisite for endothelial apoptosis. This contention is supported by the observation that monounsaturated oleic acid hardly affects both endothelial apoptosis and proliferation.
Accelerated apoptosis of vascular cells (21, 22) and an associated delay in cell cycle progression, affecting morphology and impairing function of the endothelial monolayer, are seen as a key event for initiation and progression of micro-and macrovascular disease (11, 12, 22) . Thus, our finding that up to 300µmol/l oleic acid-in contrast to stearic acid and PUFAs-do not trigger endothelial apoptosis is in line with the contention that a high intake of saturated fatty acids (C18:0) or PUFAs (C18:2ω6, C18:3ω6, C20:4ω6) contributes to (57) (58) (59) , whereas oleic acid (C18:1ω9)-the predominant fatty acid in olive oil and the Mediterranean diet-attenuates the development of atherosclerosis (60, 61) .
FFA concentrations used in this study are-with respect to stearic, oleic, and linoleic acidwithin the range of physiologic concentrations (62) . Under certain pathophysiologic conditions (1, 3, 4) , systemic plasma FFA concentrations can rise to the millimolar range, and particularly endothelial cells might be exposed to excessively high FFA concentrations due to local lipolysis of lipoprotein triglycerides by endothelium-bound lipoprotein lipase.
An almost identical proapoptotic activity of unconjugated linoleic acid compared with that of albumin-conjugated linoleic acid excludes an effect of the FFA/albumin ratio in FFA-mediated endothelial apoptosis.
In conclusion, increased FFA concentrations directly induce cell cycle arrest and apoptosis in vascular endothelial cells. Experiments performed with human plasma samples with elevated FFA concentrations (after intralipid/heparin infusion) support the clinical relevance of the results obtained by defined FFA stimulation. The finding that saturated and polyunsaturated (ω6) FFAs, but not oleic acid, inhibit cell cycle progression and trigger endothelial apoptosis suggests that FFA structure could differentially affect endothelial cell proliferation and apoptosis, both representing key factors in the development of micro-and macrovascular dysfunction. µmol/l total FFAs) or postintralipid plasma (diluted to 369±24 µmol/l total FFAs) and compared with cells treated with preheparin-or preintralipid plasma (diluted to 43 µmol/l and 59±23 µmol/l total FFAs, respectively). Pre-and postintralipid plasma were obtained from four volunteers (each open symbol-diamonds, squares, triangles and circlesrepresents one volunteer). Pre-and post heparin plasma were obtained from one patient (represented by the black circles). HUVECs were exposed for 24 h (A) (9 individual HUVEC cultures) and 48 h (B) (10 individual HUVEC cultures) to the respective plasma dilutions. 24 h: **P<0.01; 48 h: ***P<0.001 both vs. low FFA-control (preintralipid and preheparin plasma). , and pre-pro-endothelin-1 (C) was determined and compared with intra-individual ethanol-treated control cultures (set to 100%). Because there were no significant differences between the different FFAs used, data were pooled for statistical analyses. In addition, autoradiographies of representative HUVEC cultures exposed to 100-300 µmol/l of the different FFAs are shown for IκBα (A), endothelial NO-synthase (B), and pre-pro-endothelin-1(C). *P<0.05, **P<0.01, ***P<0.001 vs. ethanol-treated control (set to 100%). WAF-1/Cip1 (B) in HUVECs. HUVECs (n=5) were exposed (24 h) to 300 µmol/l stearic, oleic, linoleic, linolenic, and arachidonic acid and compared with intra-individual ethanol-treated control cultures (set to 100%). A) Cyclin D3 expression was reduced to similar levels by all tested FFAs, whereas the increase in p21 WAF-1/Cip1 protein expression (B) (as represented by the black bars) strongly correlated (r=0.94, P<0.01) with the number of cells in G 0 /G 1 phase of the cell cycle (as represented by the black circles). *P<0.05, **P<0.01 vs. ethanol-treated control (set to 100%).
